RxDoctor Payments Data

Richard Rupp

Adolescent Medicine · Galveston, TXNPI 1700893625

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $15,147 of the $20,135 with a category attached, or 75.2%. GSK accounts for 60.3% of it on its own, with 3 other manufacturers making up the rest. Among adolescent medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$20,135in general payments, 2019–2025

Across 45 payments — averaging $447.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$12K
  • Merck$5K
  • Modernatx, Inc.$2K
  • Pfizer$2K
$7,694,134in research payments, 2019–2025

Across 1,012 payments — averaging $7602.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$4.4M
  • Merck$2.3M
  • GSK$475K
  • Modernatx, Inc.$307K
  • Sanofi Pasteur Inc.$216K

What the payments were for

  • Consulting fees$15,14775%
  • Travel & lodging$3,07115%
  • Food & beverage$1,8989%
  • Gifts$200%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK11$12,147
Merck21$4,548
Modernatx, Inc.7$1,728
Pfizer6$1,712

How this compares

$20,135 in reported general payments places this provider in the 95th percentile of 68 adolescent medicine providers in Texas.

See all adolescent medicine providers in Texas →

Other adolescent medicine in Galveston

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →